10 drugs targeted for Medicare price negotiations as Biden pitches cost reductions
Headline from Wyoming Tribune Eagle, on the newest of 2 developments
President Joe Biden is touting his administration's efforts to lower medical costs. Officials on Tuesday announced the first 10 drugs that would be targeted for Medicare price negotiations. The popular
Wyoming Tribune Eagle's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
Developments in this update
2 dated developments, oldest first, newest marked. Each is named by one outlet's own headline; open its reports to see every outlet that covered it.
Billion-dollar drugs’ makers set to face their first US price negotiations
Headline from The Columbian ·
Newest
10 drugs targeted for Medicare price negotiations as Biden pitches cost reductions
Some of the most widely used drugs in the U.S. may be heading for lower prices under Medicare, a move that could save taxpayers billions of dollars and squeeze profits for big pharmaceutical companies
Some of the most widely used drugs in the U.S. may be heading for lower prices under Medicare, a move that could save taxpayers billions of dollars and squeeze profits
President Joe Biden's administration released a list of 10 drugs for which the federal government will take a first-ever step: negotiating drug prices directly with the manufacturer.
President Joe Biden’s administration Tuesday released a list of 10 drugs for which the federal government will take a first-ever step: negotiating drug prices directly with the manufacturer.
President Joe Biden is touting his administration's efforts to lower medical costs. Officials on Tuesday announced the first 10 drugs that would be targeted for Medicare price negotiations. The popular
The Biden admin unveiled the first 10 drugs that will be subject to Medicare price negotiations -- a milestone for Democrats in their push to lower health care costs.
The Biden administration unveiled Tuesday the names of the first 10 drugs subject to price negotiations in Medicare, including blood thinners and diabetes medications.
WASHINGTON (AP) — President Joe Biden's administration will announce on Tuesday the first prescription drugs being targeted by the U.S. government for price negotiations as part of an effort to lower Medicare costs.
The government will negotiate new prices for the commonly prescribed drugs, but the cuts won't take effect until 2026. In the meantime, drugmakers are fighting the negotiations with lawsuits.
The Biden administration on Tuesday revealed a list of ten drugs subject to price negotiations between Medicare and major pharmaceutical companies. Negotiations between drug manufacturers and Medicare […]
A pharmaceuticals lobbying group is criticizing the list of drugs President Joe Biden says he’s targeting for price negotiations to cut Medicare costs. The Pharmaceutical Research and Manufacturers of America
The Inflation Reduction Act gives the federal government power to negotiate the price of certain drugs for Medicare. It marks a change to prescription drug policy that's been decades in the making.
Eliquis, Jardiance and eight other medications are on the Biden administration's list of drugs for which prices will be negotiated directly with the manufacturer.
